Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Open accessThe DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Abstract
Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected contribution of thrombotic events to morbidity and mortality in COVID-19 patients has prompted a search for novel potential options for preventing COVID-19-associated thrombotic disease. In this article by the Global COVID-19 Thrombosis Collaborative Group, we describe novel dosing approaches for commonly used antithrombotic agents (especially heparin-based regimens) and the potential use of less widely used antithrombotic drugs in the absence of confirmed thrombosis. Although these therapies may have direct antithrombotic effects, other mechanisms of action, including anti-inflammatory or antiviral effects, have been postulated. Based on survey results from this group of authors, we suggest research priorities for specific agents and subgroups of patients with COVID-19. Further, we review other agents, including immunomodulators, that may have antithrombotic properties. It is our hope that the present document will encourage and stimulate future prospective studies and randomized trials to study the safety, efficacy, and optimal use of these agents for prevention or management of thrombosis in COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationZhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Self-citationClinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,885
Self-citationCRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,583
Rivaroxaban with or without aspirin in stable cardiovascular disease
Eikelboom, J. W., Connolly, S. J., Bosch, J., Dagenais, G. R., Hart, R. G., Shestakovska, O., Diaz, R., Alings, M., Lonn, E. M., Anand, S. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709118 · Cited by 2,438
Self-citationWahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,347
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study
Wichmann, D., Sperhake, J.-P., Lütgehetmann, M., Steurer, S., Edler, C., Heinemann, A., Heinrich, F., Mushumba, H., Kniep, I., Schröder, A. S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2003 · Cited by 2,274
Cummings, M. J., Baldwin, M. R., Abrams, D., Jacobson, S. D., Meyer, B. J., Balough, E. M., Aaron, J. G., Claassen, J., Rabbani, L. E., Hastie, J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31189-2 · Cited by 2,212
Magro, C., Mulvey, J. J., Berlin, D., Nuovo, G., Salvatore, S., Harp, J., Baxter-Stoltzfus, A., & Laurence, J. (2020) · Translational Research · doi:10.1016/j.trsl.2020.04.007 · Cited by 2,183
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., De Leacy, R. A., Shigematsu, T., Ladner, T. R., Yaeger, K. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,116
Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J., Biondi-Zoccai, G., Brown, T. S., Der Nigoghossian, C., Zidar, D. A., Haythe, J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.031 · Cited by 2,017
Self-citationISTH interim guidance on recognition and management of coagulopathy in COVID‐19
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C., & Iba, T. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14810 · Cited by 1,925
Self-citationRivaroxaban in Patients with a Recent Acute Coronary Syndrome
Mega, J. L., Braunwald, E., Wiviott, S. D., Bassand, J.-P., Bhatt, D. L., Bode, C., Burton, P., Cohen, M., Cook-Bruns, N., Fox, K. A. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112277 · Cited by 1,897
Self-citationPrevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Cui, S., Chen, S., Li, X., Liu, S., & Wang, F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14830 · Cited by 1,806
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.002 · Cited by 1,751
COVID-19 and cardiovascular disease
Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., Jain, S. S., Burkhoff, D., Kumaraiah, D., Rabbani, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046941 · Cited by 1,738
Self-citationLippi, G., Plebani, M., & Henry, B. M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.022 · Cited by 1,706
Self-citationPlatelets and the immune continuum
Semple, J. W., Italiano, J. E., & Freedman, J. (2011) · Nature Reviews Immunology · doi:10.1038/nri2956 · Cited by 1,692
Hematological findings and complications of COVID‐19
Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. N., Politou, M., Psaltopoulou, T., Gerotziafas, G., & Dimopoulos, M. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25829 · Cited by 1,673
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.041 · Cited by 1,601
High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial
Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,419
Panigada, M., Bottino, N., Tagliabue, P., Grasselli, G., Novembrino, C., Chantarangkul, V., Pesenti, A., Peyvandi, F., & Tripodi, A. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14850 · Cited by 1,315
Drotrecogin Alfa (Activated) in Adults with Septic Shock
Ranieri, V. M., Thompson, B. T., Barie, P. S., Dhainaut, J.-F., Douglas, I. S., Finfer, S., Gårdlund, B., Marshall, J. C., Rhodes, A., Artigas, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202290 · Cited by 1,309
Pleiotropic Effects of Statins on the Cardiovascular System
Oesterle, A., Laufs, U., & Liao, J. K. (2017) · Circulation Research · doi:10.1161/circresaha.116.308537 · Cited by 1,247
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Jose, R. J., & Manuel, A. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30216-2 · Cited by 1,240
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Han, H., Yang, L., Liu, R., Liu, F., Wu, K.-L., Li, J., Liu, X.-H., & Zhu, C.-L. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0188 · Cited by 1,223
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
SARS-CoV-2 and viral sepsis: observations and hypotheses
Li, H., Liu, L., Zhang, D., Xu, J., Dai, H., Tang, N., Su, X., & Cao, B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30920-x · Cited by 1,178
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Arabi, Y. M., Mandourah, Y., Al-Hameed, F., Sindi, A. A., Almekhlafi, G. A., Hussein, M. A., Jose, J., Pinto, R., Al-Omari, A., Kharaba, A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1172oc · Cited by 1,122
COVID-19: combining antiviral and anti-inflammatory treatments
Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., & Richardson, P. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30132-8 · Cited by 1,117
Garcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2291 · Cited by 1,091
Self-citationRivaroxaban in Peripheral Artery Disease after Revascularization
Bonaca, M. P., Bauersachs, R. M., Anand, S. S., Debus, E. S., Nehler, M. R., Patel, M. R., Fanelli, F., Capell, W. H., Diao, L., Jaeger, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2000052 · Cited by 1,045
Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101766 · Cited by 978
Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction
Rosenson, R. S., & Tangney, C. C. (1998) · JAMA · doi:10.1001/jama.279.20.1643 · Cited by 954
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
Morrow, D. A., Braunwald, E., Bonaca, M. P., Ameriso, S. F., Dalby, A. J., Fish, M. P., Fox, K. A. A., Lipka, L. J., Liu, X., Nicolau, J. C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200933 · Cited by 948
Paranjpe, I., Fuster, V., Lala, A., Russak, A. J., Glicksberg, B. S., Levin, M. A., Charney, A. W., Narula, J., Fayad, Z. A., Bagiella, E., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.001 · Cited by 920
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000624 · Cited by 907
ST-Segment Elevation in Patients with Covid-19 — A Case Series
Bangalore, S., Sharma, A., Slotwiner, A., Yatskar, L., Harari, R., Shah, B., Ibrahim, H., Friedman, G. H., Thompson, C., Alviar, C. L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009020 · Cited by 844
A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
Glynn, R. J., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900241 · Cited by 752
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Cohen, A. T., Spiro, T. E., Büller, H. R., Haskell, L., Hu, D., Hull, R., Mebazaa, A., Merli, G., Schellong, S., Spyropoulos, A. C., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1111096 · Cited by 607
Self-citationComplete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation
Zarbock, A., Singbartl, K., & Ley, K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29499 · Cited by 601
Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients
Goldhaber, S. Z., Leizorovicz, A., Kakkar, A. K., Haas, S. K., Merli, G., Knabb, R. M., & Weitz, J. I. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1110899 · Cited by 547
Self-citationWang, J., Hajizadeh, N., Moore, E. E., McIntyre, R. C., Moore, P. K., Veress, L. A., Yaffe, M. B., Moore, H. B., & Barrett, C. D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14828 · Cited by 536
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
Bowles, L., Platton, S., Yartey, N., Dave, M., Lee, K., Hart, D. P., MacDonald, V., Green, L., Sivapalaratnam, S., Pasi, K. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2013656 · Cited by 487
Johannesdottir, S. A., Horváth-Puhó, E., Dekkers, O. M., Cannegieter, S. C., Jørgensen, J. O. L., Ehrenstein, V., Vandenbroucke, J. P., Pedersen, L., & Sørensen, H. T. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.122 · Cited by 465
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
Cohen, A. T., Harrington, R. A., Goldhaber, S. Z., Hull, R. D., Wiens, B. L., Gold, A., Hernandez, A. F., & Gibson, C. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1601747 · Cited by 441
Self-citationDifference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Yin, S., Huang, M., Li, D., & Tang, N. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02105-8 · Cited by 434
Factors at Admission Associated With Bleeding Risk in Medical Patients
Decousus, H., Tapson, V. F., Bergmann, J.-F., Chong, B. H., Froehlich, J. B., Kakkar, A. K., Merli, G. J., Monreal, M., Nakamura, M., Pavanello, R., et al. (2011) · Chest · doi:10.1378/chest.09-3081 · Cited by 431
Self-citationInhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
Lang, J., Yang, N., Deng, J., Liu, K., Yang, P., Zhang, G., & Jiang, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023710 · Cited by 427
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report
Kearon, C., Akl, E. A., Ornelas, J., et al. (2016) · Archive ouverte UNIGE (University of Geneva) · Cited by 427
Huerta, C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.935 · Cited by 408
The versatile heparin in COVID-19
Thachil, J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14821 · Cited by 404
Looney, M. R., Nguyen, J. X., Hu, Y., Van Ziffle, J. A., Lowell, C. A., & Matthay, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38432 · Cited by 396
Self-citationDeDiego, M. L., Nieto-Torres, J. L., Regla-Nava, J. A., Jimenez-Guardeño, J. M., Fernandez-Delgado, R., Fett, C., Castaño-Rodriguez, C., Perlman, S., & Enjuanes, L. (2014) · Journal of Virology · doi:10.1128/jvi.02576-13 · Cited by 394
Acute limb ischemia in patients with COVID-19 pneumonia
Bellosta, R., Luzzani, L., Natalini, G., Pegorer, M. A., Attisani, L., Cossu, L. G., Ferrandina, C., Fossati, A., Conti, E., Bush, R. L., et al. (2020) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2020.04.483 · Cited by 392
Zöller, B., Li, X., Sundquist, J., & Sundquist, K. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61306-8 · Cited by 366
Zhai, Z., Li, C., Chen, Y., Gerotziafas, G., Zhang, Z., Wan, J., Liu, P., Elalamy, I., Wang, C., & On behalf of the Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1710019 · Cited by 365
Schreiber, K., Sciascia, S., de Groot, P. G., Devreese, K., Jacobsen, S., Ruiz-Irastorza, G., Salmon, J. E., Shoenfeld, Y., Shovman, O., & Hunt, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.103 · Cited by 359
Self-citationVincent, J.-L., Francois, B., Zabolotskikh, I., Daga, M. K., Lascarrou, J.-B., Kirov, M. Y., Pettilä, V., Wittebole, X., Meziani, F., Mercier, E., et al. (2019) · JAMA · doi:10.1001/jama.2019.5358 · Cited by 357
Self-citationMarietta, M., Ageno, W., Artoni, A., Candia, E. D., Gresele, P., Marchetti, M., Marcucci, R., & Tripodi, A. (2020) · Blood transfusion · doi:10.2450/2020.0083-20 · Cited by 348
Self-citationAl-Abdallat, M. M., Payne, D. C., Alqasrawi, S., Rha, B., Tohme, R. A., Abedi, G. R., Al Nsour, M., Iblan, I., Jarour, N., Farag, N. H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu359 · Cited by 308
Anti‐platelet therapy: phosphodiesterase inhibitors
Gresele, P., Momi, S., & Falcinelli, E. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04034.x · Cited by 304
Platelets in defense against bacterial pathogens
Yeaman, M. R. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0210-4 · Cited by 303
Pixley, R. A., De La Cadena, R., Page, J. D., Kaufman, N., Wyshock, E. G., Chang, A., Taylor, F. B., & Colman, R. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116201 · Cited by 278
The role of platelets in mediating a response to human influenza infection
Koupenova, M., Corkrey, H. A., Vitseva, O., Manni, G., Pang, C. J., Clancy, L., Yao, C., Rade, J., Levy, D., Wang, J. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09607-x · Cited by 275
Frantzeskaki, F., Armaganidis, A., & Orfanos, S. E. (2017) · Respiration · doi:10.1159/000453002 · Cited by 274
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
Liu, X., Li, Z., Liu, S., Sun, J., Chen, Z., Jiang, M., Zhang, Q., Wei, Y., Wang, X., Huang, Y.-Y., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.008 · Cited by 274
Whyte, C. S., Morrow, G. B., Mitchell, J. L., Chowdary, P., & Mutch, N. J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14872 · Cited by 273
Bessière, F., Roccia, H., Delinière, A., Charrière, R., Chevalier, P., Argaud, L., & Cour, M. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1787 · Cited by 270
Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?
Campbell, C. M., & Kahwash, R. (2020) · Circulation · doi:10.1161/circulationaha.120.047419 · Cited by 267
Corticosteroids as adjunctive therapy in the treatment of influenza
Rodrigo, C., Leonardi-Bee, J., Nguyen-Van-Tam, J., & Lim, W. S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010406.pub2 · Cited by 264
Activated protein C: biased for translation
Griffin, J. H., Zlokovic, B. V., & Mosnier, L. O. (2015) · Blood · doi:10.1182/blood-2015-02-355974 · Cited by 257
Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice
Edwards, M. H., Pierangeli, S., Liu, X., Barker, J. H., Anderson, G., & Harris, E. N. (1997) · Circulation · doi:10.1161/01.cir.96.12.4380 · Cited by 250
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
Spyropoulos, A. C., Ageno, W., Albers, G. W., Elliott, C. G., Halperin, J. L., Hiatt, W. R., Maynard, G. A., Steg, P. G., Weitz, J. I., Suh, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805090 · Cited by 248
Self-citationThe role of platelets in sepsis
van ’t Veer, C., Poll, T. V. D., & de Stoppelaar, S. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-02-0126 · Cited by 247
Hydroxychloroquine Reverses Platelet Activation Induced by Human IgG Antiphospholipid Antibodies
Espinola, R., Ghara, A., Harris, E., & Pierangeli, S. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613033 · Cited by 240
Vandiver, J. W., & Vondracek, T. G. (2012) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.2011.01049.x · Cited by 236
Vandermeer, M. L., Thomas, A. R., Kamimoto, L., Reingold, A., Gershman, K., Meek, J., Farley, M. M., Ryan, P., Lynfield, R., Baumbach, J., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jir695 · Cited by 224
Thrombocytopenia impairs host defense in gram-negative pneumonia–derived sepsis in mice
de Stoppelaar, S. F., van ’t Veer, C., Claushuis, T. A. M., Albersen, B. J. A., Roelofs, J. J. T. H., & van der Poll, T. (2014) · Blood · doi:10.1182/blood-2014-05-573915 · Cited by 220
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A comment
Barrett, C. D., Moore, H. B., Yaffe, M. B., & Moore, E. E. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14860 · Cited by 219
Kor, D. J., Carter, R. E., Park, P. K., Festic, E., Banner-Goodspeed, V. M., Hinds, R., Talmor, D., Gajic, O., Ware, L. B., Gong, M. N., et al. (2016) · JAMA · doi:10.1001/jama.2016.6330 · Cited by 216
Heparin-Induced Thrombocytopenia
Salter, B. S., Weiner, M. M., Trinh, M. A., Heller, J., Evans, A. S., Adams, D. H., & Fischer, G. W. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.073 · Cited by 215
Mycroft-West, C., Su, D., Elli, S., Li, Y., Guimond, S., Miller, G., Turnbull, J., Yates, E., Guerrini, M., Fernig, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.29.971093 · Cited by 212
VAN ZAANE, B., NUR, E., SQUIZZATO, A., GERDES, V. E. A., BÜLLER, H. R., DEKKERS, O. M., & BRANDJES, D. P. M. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04034.x · Cited by 210
Petri, M. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-010-0141-y · Cited by 206
Statins as Antithrombotic Drugs
Violi, F., Calvieri, C., Ferro, D., & Pignatelli, P. (2013) · Circulation · doi:10.1161/circulationaha.112.145334 · Cited by 205
More than an anticoagulant: Do heparins have direct anti-inflammatory effects?
Poterucha, T. J., Libby, P., & Goldhaber, S. Z. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-08-0620 · Cited by 199
Self-citationCorticosteroids as adjunctive therapy in the treatment of influenza
Lansbury, L., Rodrigo, C., Leonardi-Bee, J., Nguyen-Van-Tam, J., & Lim, W. S. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010406.pub3 · Cited by 193
Xiang, B., Zhang, G., Guo, L., Li, X.-A., Morris, A. J., Daugherty, A., Whiteheart, S. W., Smyth, S. S., & Li, Z. (2013) · Nature Communications · doi:10.1038/ncomms3657 · Cited by 190
Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis
Taylor, P. C., Weinblatt, M. E., Burmester, G. R., Rooney, T. P., Witt, S., Walls, C. D., Issa, M., Salinas, C. A., Saifan, C., Zhang, X., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40841 · Cited by 176
Monitoring unfractionated heparin with the aPTT: Time for a fresh look
Hirsh, J., & Eikelboom, J. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-05-0290 · Cited by 174
Self-citationBrass, L. M., Lichtman, J. H., Wang, Y., Gurwitz, J. H., Radford, M. J., & Krumholz, H. M. (2000) · Stroke · doi:10.1161/01.str.31.8.1802 · Cited by 170
Self-citationTesta, S., Prandoni, P., Paoletti, O., Morandini, R., Tala, M., Dellanoce, C., Giorgi‐Pierfranceschi, M., Betti, M., Danzi, G. B., Pan, A., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14871 · Cited by 169
Correction: Antiphospholipid syndrome
Schreiber, K., Sciascia, S., de Groot, P. G., Devreese, K., Jacobsen, S., Ruiz-Irastorza, G., Salmon, J. E., Shoenfeld, Y., Shovman, O., & Hunt, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.5 · Cited by 167
Self-citationObi, A. T., Tignanelli, C. J., Jacobs, B. N., Arya, S., Park, P. K., Wakefield, T. W., Henke, P. K., & Napolitano, L. M. (2019) · Journal of Vascular Surgery: Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2018.08.010 · Cited by 166
Storey, R. F., James, S. K., Siegbahn, A., Varenhorst, C., Held, C., Ycas, J., Husted, S. E., Cannon, C. P., Becker, R. C., Steg, P. G., et al. (2014) · Platelets · doi:10.3109/09537104.2013.842965 · Cited by 162
A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases
Lee, J. J., & Pope, J. E. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0435-y · Cited by 149
Adjuvant corticosteroid therapy for critically ill patients with COVID-19
Lu, X., Chen, T., Wang, Y., Wang, J., Zhang, B., Li, Y., & Yan, F. (2020) · Critical Care · doi:10.1186/s13054-020-02964-w · Cited by 146
Ito, T., Thachil, J. V., Asakura, H., Levy, J. H., & Iba, T. (2019) · Critical Care · doi:10.1186/s13054-019-2552-0 · Cited by 136
Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia
Sexton, T. R., Zhang, G., Macaulay, T. E., Callahan, L. A., Charnigo, R. J., Vsevolozhskaya, O. A., Li, Z., & Smyth, S. S. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.05.005 · Cited by 133
Coronaviridae and SARS-associated Coronavirus Strain HSR1
Vicenzi, E., Canducci, F., Pinna, D., Mancini, N., Carletti, S., Lazzarin, A., Bordignon, C., Poli, G., & Clementi, M. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1003.030683 · Cited by 132
Activated Platelets Enhance IL-10 Secretion and Reduce TNF-α Secretion by Monocytes
Gudbrandsdottir, S., Hasselbalch, H. C., & Nielsen, C. H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201103 · Cited by 129
Chang, J. C. (2019) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029619887437 · Cited by 128
Kong, F., Ye, B., Lü, L., Cai, X., Huang, W., & Huang, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.04.043 · Cited by 123
Heparin-Induced Thrombocytopenia in Critically Ill Patients
Warkentin, T. E. (2015) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1398381 · Cited by 118
Vivas, D., Roldán, V., Esteve‐Pastor, M. A., Roldán, I., Tello‐Montoliu, A., Ruiz-Nodar, J. M., Cosín-Sales, J., Martínez, J. M. G., Consuegra, L., Ferreiro, J. L., et al. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.04.006 · Cited by 118
Tucker, E. I., Verbout, N. G., Leung, P. Y., Hurst, S., McCarty, O. J. T., Gailani, D., & Gruber, A. (2012) · Blood · doi:10.1182/blood-2011-10-386185 · Cited by 113
Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
Yuan, S. (2015) · mBio · doi:10.1128/mbio.01120-15 · Cited by 109
Considerations for Statin Therapy in Patients with COVID‐19
Dashti‐Khavidaki, S., & Khalili, H. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2397 · Cited by 107
Allingstrup, M., Wetterslev, J., Ravn, F., Møller, A. M., & Afshari, A. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4225-7 · Cited by 104
Lancellotti, P., Musumeci, L., Jacques, N., Servais, L., Goffin, E., Pirotte, B., & Oury, C. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1189 · Cited by 103
Chen, W., Janz, D. R., Bastarache, J. A., May, A. K., O’Neal, H. R., Bernard, G. R., & Ware, L. B. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000789 · Cited by 100
Casini, A., Alberio, L., Angelillo‐Scherrer, A., Fontana, P., Gerber, B., Graf, L., Hegemann, I., Korte, W. C., Hovinga, J. A. K., Lecompte, T., et al. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20247 · Cited by 100
Pulmonary thrombosis in 2019‐nCoV pneumonia?
Marongiu, F., Grandone, E., & Barcellona, D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14818 · Cited by 99
Treatment of Severe Acute Respiratory Distress Syndrome: A Final Report on a Phase I Study
Hardaway, R. M., Harke, H., Tyroch, A. H., Williams, C. H., Vazquez, Y., & Krause, G. F. (2001) · The American Surgeon · doi:10.1177/000313480106700417 · Cited by 98
Vivas, D., Roldán, V., Esteve‐Pastor, M. A., Roldán, I., Tello‐Montoliu, A., Ruiz-Nodar, J. M., Cosín-Sales, J., Martínez, J. M. G., Consuegra, L., Ferreiro, J. L., et al. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.04.025 · Cited by 97
Aungraheeta, R., Conibear, A. E., Butler, M., Kelly, E., Nylander, S., Mumford, A. D., & Mundell, S. J. (2016) · Blood · doi:10.1182/blood-2016-03-707844 · Cited by 96
Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells
Ghezzi, S., Cooper, L. C., Rubio, A., Pagani, I., Capobianchi, M. R., Ippolito, G., Pelletier, J., Meneghetti, M. C. Z., de Lima, M. A., Skidmore, M. A., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2016.12.023 · Cited by 94
Activated protein C action in inflammation
Sarangi, P. P., Lee, H., & Kim, M. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08020.x · Cited by 93
Boyle, A. J., Gangi, S. D., Hamid, U. I., Mottram, L.-J., McNamee, L., White, G., Cross, L. M., McNamee, J. J., O’Kane, C. M., & McAuley, D. F. (2015) · Critical Care · doi:10.1186/s13054-015-0846-4 · Cited by 93
Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic
Obi, A. T., Barnes, G. D., Wakefield, T. W., Brown, S., Eliason, J. L., Arndt, E., & Henke, P. K. (2020) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2020.04.009 · Cited by 91
Self-citationSchein, J. R., White, C. M., Nelson, W. W., Kluger, J., Mearns, E. S., & Coleman, C. I. (2016) · Thrombosis Journal · doi:10.1186/s12959-016-0088-y · Cited by 89
Moore, H. B., Barrett, C. D., Moore, E. E., McIntyre, R. C., Moore, P. K., Talmor, D. S., Moore, F. A., & Yaffe, M. B. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002694 · Cited by 88
Using heparin molecules to manage COVID‐2019
Liu, J., Li, J., Arnold, K., et al. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12353 · Cited by 79
Silasi‐Mansat, R., Keshari, R. S., Lupu, C., van Rensburg, W. J. J., Chaaban, H., Regmi, G., Шаманаев, А. Ю., Shatzel, J. J., Puy, C., Lorentz, C. U., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018029983 · Cited by 75
Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke
Huang, X., Moreton, F. C., Kalladka, D., Cheripelli, B. K., Macisaac, R. L., Tait, R. C., & Muir, K. W. (2015) · Stroke · doi:10.1161/strokeaha.115.011290 · Cited by 74
Marsousi, N., Daali, Y., Fontana, P., Reny, J., Ancrenaz, V., Calmy, A., Rudaz, S. L., Desmeules, J. A., & Samer, C. F. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0637-6 · Cited by 74
Panka, B., de Grooth, H., de Man, A., Looney, M. R., & Tuinman, P. R. (2016) · Shock · doi:10.1097/shk.0000000000000745 · Cited by 71
Corticosteroids and ARDS: A review of treatment and prevention evidence
Khilnani, G., & Hadda, V. (2011) · Lung India · doi:10.4103/0970-2113.80324 · Cited by 70
Gross, K., Dunn, S. P., Feola, D. J., Martin, C. A., Charnigo, R. J., Li, Z., Abdel‐Latif, A., & Smyth, S. S. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0833-4 · Cited by 65
Valeriani, E., Squizzato, A., Gallo, A., Porreca, E., Vincent, J., Iba, T., Hagiwara, A., & Nisio, M. D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14812 · Cited by 65
Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
Liu, C., Ma, Y., Su, Z., Zhao, R., Zhao, X., Nie, H., Xu, P., Zhu, L., Zhang, M., Li, X., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01898 · Cited by 63
Hydroxychloroquine and postoperative thromboembolism after total hip replacement
Loudon, J. R. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90364-6 · Cited by 60
Emergence of institutional antithrombotic protocols for coronavirus 2019
Cohoon, K. P., Mahé, G., Tafur, A. J., & Spyropoulos, A. C. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12358 · Cited by 58
Self-citationSchreiber, K. I., Breen, K. A., Parmar, K., Rand, J. H., Wu, X.-X., & Hunt, B. J. (2017) · Rheumatology · doi:10.1093/rheumatology/kex378 · Cited by 57
Self-citationRivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Cohen, A. T., Spiro, T. E., & Spyropoulos, A. C. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1303641 · Cited by 54
Self-citationBarrett, C. D., Moore, H. B., Moore, E. E., McIntyre, R. C., Moore, P. K., Burke, J., Hua, F., Apgar, J. F., Talmor, D. S., Sauaia, A., et al. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12357 · Cited by 50
Mahmoud, A. A. A., Mahmoud, H. E., Mahran, M., & khaled, M. H. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.05.035 · Cited by 48
RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19
Akima, S., McLintock, C., & Hunt, B. J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14853 · Cited by 48
Self-citationSulodexide for treating venous leg ulcers
Wu, B., Lu, J., Yang, M. J., & Xu, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010694.pub2 · Cited by 46
Hagiwara, S., Iwasaka, H., Hidaka, S., Hishiyama, S., & Noguchi, T. (2008) · Critical Care · doi:10.1186/cc6851 · Cited by 45
Schmidt, S. A. J., Horváth–Puhó, E., & Dekkers, O. M. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.09.021 · Cited by 40
A Systematic Summary of Systematic Reviews on Anticoagulant Therapy in Sepsis
Murao, S., & Yamakawa, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111869 · Cited by 39
Bikdeli, B., Chatterjee, S., Kirtane, A. J., Parikh, S. A., Andreozzi, G. M., Desai, N. R., Francese, D. P., Gibson, C. M., Piazza, G., Goldhaber, S. Z., et al. (2020) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0040-1716874 · Cited by 38
Self-citationRivaroxaban in Peripheral Artery Disease after Revascularization
Ultee, K. H. J., Steunenberg, S. L., & Schouten, O. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2030413 · Cited by 37
Cornet, A. D., Groeneveld, A. B. J., Hofstra, J. J., Vlaar, A. P. J., Tuinman, P. R., van Lingen, A., Levi, M. M., Girbes, A. R. J., Schultz, M. J., & Beishuizen, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090983 · Cited by 35
Wang, L., Li, H., Gu, X., Wang, Z., Liu, S., & Chen, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154754 · Cited by 33
Johansson, E., Forsberg, K., & Johnsson, H. (2009) · Haemostasis · doi:10.1159/000214391 · Cited by 32
Iba, T., & Miyasho, T. (2008) · Critical Care · doi:10.1186/cc6943 · Cited by 25
Heparinoids Danaparoid and Sulodexide as clinically used drugs
Dou, H., Song, A., Jia, S., & Zhang, L. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.02.005 · Cited by 25
Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population
Sun, W. M., Li, Z.-R., Shi, Z.-C., Zhang, N., & Zhang, Y. (2006) · International Orthopaedics · doi:10.1007/s00264-005-0067-6 · Cited by 23
Bikdeli, B., McAndrew, T., Crowley, A., Chen, S., Mehdipoor, G., Redfors, B., Liu, Y., Zhang, Z., Liu, M., Zhang, Y., et al. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1700872 · Cited by 19
Self-citationSulodexide for treating venous leg ulcers
Wu, B., Lu, J., Yang, M. J., & Xu, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010694 · Cited by 18
COVID-19 and cardiovascular disease
Suri, P., & Arora, V. M. (2020) · Journal of Medical and Scientific Research · doi:10.17727/jmsr.2020/8s1-8 · Cited by 15
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Self-citationExtrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Self-citationINSPIRATION Investigators, Mazloomzadeh, S., Khaleghparast, S., Ghadrdoost, B., Mousavizadeh, M., Baay, M. R., Noohi, F., Sharifnia, H., Ahmadi, A., Tavan, S., et al. (2021) · JAMA · doi:10.1001/jama.2021.4152 · Cited by 625
Self-citationChao, T.-F., Joung, B., Takahashi, Y., Lim, T. W., Choi, E.-K., Chan, Y.-H., Guo, Y., Sriratanasathavorn, C., Oh, S., Okumura, K., et al. (2022) · Thrombosis and Haemostasis · doi:10.1055/s-0041-1739411 · Cited by 473
Self-citationIncidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019
Jiménez, D., García-Sanchez, A., Rali, P., Muriel, A., Bikdeli, B., Ruiz-Artacho, P., Le Mao, R., Rodríguez, C., Hunt, B. J., & Monreal, M. (2021) · Chest · doi:10.1016/j.chest.2020.11.005 · Cited by 468
Self-citation
Metadata
- Authors
- Madhavan, M. V., Bikdeli, B., Gupta, A., Jimenez, D., Burton, J. R., Der Nigoghossian, C., Chuich, T., Nouri, S. N., Dreyfus, I., Driggin, E., Sethi, S., Sehgal, K., Chatterjee, S., Ageno, W., Madjid, M., Guo, Y., Tang, L. V., Hu, Y., Bertoletti, L., Giri, J., Cushman, M., Quéré, I., Dimakakos, E. P., Gibson, C. M., Lippi, G., Favaloro, E. J., Fareed, J., Tafur, A. J., Francese, D. P., Batra, J., Falanga, A., Clerkin, K. J., Uriel, N., Kirtane, A., McLintock, C., Hunt, B. J., Spyropoulos, A. C., Barnes, G. D., Eikelboom, J. W., Weinberg, I., Schulman, S., Carrier, M., Piazza, G., Beckman, J. A., Leon, M. B., Stone, G. W., Rosenkranz, S., Goldhaber, S. Z., Parikh, S. A., Monreal, M., Krumholz, H. M., Konstantinides, S. V., Weitz, J. I., Lip, G. Y. H., & The Global COVID-19 Thrombosis Collaborative Group
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2020-05-30
- Volume
- 120
- Issue
- 07
- Pages
- 1004-1024
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W3030604488
- Cited by
- 258
- References
- 170
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.